Hemispherx Biopharma (HEB) – Corporate News
-
Hemispherx Biopharma (HEB) Announces Positive Safety & Survival Data in Phase 1 Stage 4 Ovarian Cancer Clinical Study Using Ampligen
-
Hemispherx Biopharma (HEB) CFO Adam Pascale to Retire
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to HEB Stock Lookup